Summary & Overview
CPT 55880: Transrectal HIFU Ablation of Malignant Prostate Tissue
CPT code 55880 designates transrectal high intensity–focused ultrasound (HIFU) ablation of malignant prostate tissue under ultrasound guidance. The code captures a minimally invasive, image-guided oncologic procedure increasingly relevant as focal and organ-preserving prostate cancer treatments expand. Nationally, the procedure is notable for its role in surgical oncology and urology care pathways and for payers' varied coverage approaches as technologies evolve.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how CPT code 55880 is used in clinical practice, typical sites of service, and the payers commonly involved in coverage decisions. The publication summarizes benchmarking metrics where available, highlights policy considerations and recent coverage trends, and provides clinical context about the procedure's intent and setting.
This summary is intended for clinical, coding, and payer policy audiences seeking a clear, national-level description of the service represented by CPT code 55880, plus guidance on where to look for payer-specific coverage details and benchmarking data. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 55880 describes a procedure in which a provider uses a high intensity–focused ultrasound (HIFU) device inserted through the rectum to ablate malignant prostate tissue under ultrasound guidance. This is a targeted, image-guided oncologic procedure.
-
Service type: Image-guided ablative procedure for prostate malignancy
-
Typical site of service: Ambulatory surgical center or hospital outpatient setting where transrectal ultrasound-guided interventions are performed
Clinical & Coding Specifications
Clinical Context
A 69-year-old male with biopsy-proven localized prostate adenocarcinoma (Gleason 3+4), rising PSA despite prior active surveillance, is scheduled for focal high intensity–focused ultrasound treatment. The patient presents to an outpatient ambulatory surgical center or hospital-based operating room. Pre-procedure workflow includes informed consent, pre-op anesthesia evaluation (general or spinal anesthesia), ultrasound imaging for target localization, and transrectal insertion of the HIFU device. The provider uses real-time ultrasound guidance to deliver focused thermal energy to ablate malignant prostate tissue while monitoring surrounding structures. Post-procedure workflow includes recovery in PACU, immediate assessment for urinary retention and rectal bleeding, catheter placement as needed, discharge instructions, and scheduled follow-up with PSA testing and repeat imaging or biopsy as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient visit for evaluation and management | When an unrelated E/M visit occurs on the same day as the procedure and is separately identifiable |
22 | Increased procedural services | When work required is substantially greater than typically required for 55880 |
52 | Reduced services | When the procedure is partially reduced or discontinued |
53 | Discontinued procedure | When the procedure is started but terminated due to extenuating circumstances |
62 | Two surgeons | When two surgeons work together as primary surgeons performing distinct portions |
66 | Surgical team | When a team approach is used with multiple qualified surgeons |
78 | Unplanned return to the operating/procedure room by the same physician following initial procedure for a related procedure during the postoperative period | For an unplanned re-entry to address a complication |
79 | Unrelated procedure or service by the same physician during the postoperative period | When an unrelated procedure is performed during the global period |
LT | Left side | When laterality is relevant and the procedure is performed on the left prostate lobe (if laterality reporting required) |
RT | Right side | When laterality is relevant and the procedure is performed on the right prostate lobe (if laterality reporting required) |
QK | Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals | When anesthesia direction meets criteria for concurrent cases |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 363A00000X | Urology | Most common specialty performing HIFU for prostate malignancy |
| 207RH0000X | Radiology — Radiation Oncology | Specialists involved when HIFU integrated into multidisciplinary local tumor control |
| 207L00000X | Diagnostic Radiology | Provides ultrasound imaging guidance and intra-procedural interpretation |
| 363LF0000X | Female Urology | (Included for completeness though uncommon for prostate procedures) |
| 208800000X | Anesthesiology | Provides general/regional anesthesia and perioperative management |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
C61 | Malignant neoplasm of prostate | Primary indication for HIFU to ablate localized prostate cancer |
D40.0 | Neoplasm of uncertain behavior of prostate | Situations where focal therapy may be considered for atypical lesions |
N40.0 | Benign prostatic hyperplasia with lower urinary tract symptoms | Coexisting BPH may affect planning and peri-procedural urinary management |
R33.8 | Other retention of urine | Potential peri-procedural complication requiring catheterization |
R31.9 | Hematuria, unspecified | Symptom that can occur after prostate ablation and prompts evaluation |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
51701 | Insertion of temporary indwelling urethral catheter; simple (e.g., straight catheterization) | Often performed before or after HIFU for urinary drainage or retention management |
55866 | Laparoscopic radical prostatectomy | Alternative definitive surgical treatment for localized prostate cancer; may be considered in treatment planning |
76942 | Ultrasonic guidance for needle placement (e.g., diagnostic or therapeutic) | Represents ultrasound guidance procedures; intra-procedural ultrasound guidance is intrinsic to 55880 |
52000 | Cystourethroscopy, diagnostic, with or without collection of specimen(s) by brushing or washing | May be performed if hematuria or urethral concern arises peri-procedurally |
99223 | Initial hospital care, typically 70 minutes or more, per day, for the evaluation and management of a patient | Example of an E/M service that may be billed for hospital admissions related to complications |